United States Mammography Equipment Market Outlook to 2033 - Full Field Digital Mammography Equipment

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Mammography Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Mammography Equipment Market, United States, Revenue ($m), 2018-2033
3.1.1 Full Field Digital Mammography Equipment Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Mammography Equipment Market, United States, Volume (Units), 2018-2033
3.2.1 Full Field Digital Mammography Equipment Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Mammography Equipment Market, United States, Average Price ($), 2018-2033
3.4 Mammography Equipment Market, United States, Company Share by Revenue ($m), 2024

4.1 Hologic Inc
4.1.1 Company Overview
4.2 Siemens Healthineers AG
4.2.1 Company Overview
4.3 GE HealthCare Technologies Inc
4.3.1 Company Overview
4.4 Fujifilm Holdings Corp
4.4.1 Company Overview

6.1 Debt Offerings
6.1.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
6.2 Equity Offerings
6.2.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
6.2.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares

7.1 Corporate Communications
7.1.1 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board
7.1.2 Sep 11, 2024: Solis Mammography Earns Great Place to Work Certification for Third Year in a Row
7.2 Financial Announcements
7.2.1 Jul 02, 2025: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025
7.2.2 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025
7.2.3 Apr 03, 2025: Revvity to Hold Earnings Call on Monday, April 28, 2025
7.2.4 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024
7.2.5 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025
7.2.6 Jan 31, 2025: Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024
7.2.7 Jan 12, 2025: Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance
7.2.8 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
7.2.9 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025
7.2.10 Nov 12, 2024: Oxford Instruments Announces Half-Year Results
7.2.11 Nov 04, 2024: Revvity Announces Financial Results for the Third Quarter of 2024
7.2.12 Oct 07, 2024: Revvity to Hold Earnings Call on Monday, November 4, 2024
7.2.13 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
7.3 Government and Public Interest
7.3.1 Jul 10, 2025: Study: Quick, Pain-Free Breast Imaging System Shows Promise in Early Clinical Tests
7.3.2 Mar 27, 2025: Vanqua Bio to Present at the AD/PD 2025 International Conference
7.3.3 Mar 17, 2025: Enveric Biosciences Participating in BIO-Europe Spring
7.3.4 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference
7.3.5 Nov 19, 2024: Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
7.3.6 Oct 09, 2024: Livzon Pharmaceutical Group Announcement on the Approval for the New Indication of Triptorelin Acetate Microspheres for Injection
7.3.7 Oct 03, 2024: Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
7.3.8 Aug 12, 2024: FDA approves IASO Bio’s IND for equecabtagene autoleucel
7.4 Legal And Regulatory
7.4.1 Jan 08, 2025: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Teva Pharmaceuticals
7.5 Other Significant Developments
7.5.1 Oct 07, 2024: WakeMed and Siemens Healthineers Bring Vital Mammography Screenings to the Community During Breast Cancer Awareness Month
7.5.2 Oct 01, 2024: Am I Too Young for a Mammogram
7.5.3 Sep 10, 2024: New Breast Density Reporting Requirement Empowers Women with Vital Information; Susan G. Komen(R) Urges Access to Affordable Care
7.6 Product News
7.6.1 Jul 15, 2025: RSNA: AI Tool Accurately Detects Tumor Location on Breast MRI
7.6.2 Feb 26, 2025: DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at ECR2025
7.6.3 Oct 08, 2024: Tra Medical Imaging Foundation Brings Mobilemammo NW to the South Sound
7.6.4 Oct 01, 2024: Mayo Clinic Health System Discusses Advancements in Breast Cancer Screenings
7.6.5 Sep 17, 2024: Advanced 3D Mammography Detects More Breast Cancers, Fewer False Positives
7.6.6 Aug 16, 2024: Safe Seated Mammography Using Enable Me's VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18
7.7 Strategy And Business Planning
7.7.1 Jul 10, 2025: Shionogi Announces Implementation of Stibo Systems MDM Solution
7.7.2 May 12, 2025: Fujifilm Strengthens Partnership With the National Rural Health Association To Improve Access to Medical Imaging in Rural Communities
7.7.3 Oct 10, 2024: US Radiology Specialists Launches Next Phase of its Technologist Advancement Academy With Expansion Into Mammography

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer

Table 1: Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Full Field Digital Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Mammography Equipment Market, United States, Volume (Units), 2018-2033
Table 4: Full Field Digital Mammography Equipment Market, United States, Volume (Units), 2018-2033
Table 5: Mammography Equipment Market, United States, Average Price ($), 2018-2033
Table 6: Mammography Equipment Market, United States, Company Share by Revenue ($m), 2024
Table 7: Mammography Equipment Market Pipeline Products
Table 8: GE HealthCare Technologies Raises USD1 Billion in Public Offering of 4.800% Senior Notes Due 2029
Table 9: GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
Table 10: GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
Table 11: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country

Figure 1: Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Full Field Digital Mammography Equipment Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Mammography Equipment Market, United States, Volume (Units), 2018-2033
Figure 4: Full Field Digital Mammography Equipment Market, United States, Volume (Units), 2018-2033
Figure 5: Mammography Equipment Market, United States, Company Share (%), 2024